Eric P Winer Selected Research

Eric P Winer Research Topics

Disease

260	Breast Neoplasms (Breast Cancer) 10/2022 - 06/2002
162	Neoplasms (Cancer) 10/2022 - 05/2002
34	Triple Negative Breast Neoplasms 01/2022 - 12/2008
21	Brain Neoplasms (Brain Tumor) 11/2020 - 01/2006
15	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2004
14	Leukemia 01/2021 - 04/2003
13	Pathologic Complete Response 05/2022 - 02/2007
9	Neutropenia 10/2022 - 09/2007
8	Fatigue 10/2022 - 10/2013
7	Disease Progression 07/2022 - 06/2003
7	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2012
5	Cardiotoxicity 02/2022 - 12/2004
4	Infections 01/2021 - 01/2015
4	Hypertension (High Blood Pressure) 01/2020 - 10/2014
4	Diarrhea 01/2020 - 12/2014
4	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 09/2004
4	Heart Failure 10/2018 - 09/2010
4	Central Nervous System Diseases (CNS Diseases) 03/2016 - 03/2007
3	Amenorrhea 08/2021 - 01/2005
3	Circulating Neoplastic Cells 01/2021 - 11/2014
3	Nausea 01/2020 - 12/2004
3	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 11/2015 - 11/2006
3	Osteoporosis 01/2012 - 01/2005

Drug/Important Bio-Agent (IBA)

62	Hormones (Hormone)IBA 10/2022 - 08/2002
50	Trastuzumab (Herceptin)FDA Link 10/2022 - 06/2002
43	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 06/2002
34	human ERBB2 proteinIBA 10/2022 - 01/2003
31	ErbB Receptors (EGF Receptor)IBA 10/2022 - 10/2007
31	Estrogen ReceptorsIBA 01/2022 - 01/2003
25	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2003
25	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2003
25	Tamoxifen FDA LinkGeneric 01/2019 - 08/2002
23	Aromatase InhibitorsIBA 01/2019 - 08/2002
21	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
12	AnthracyclinesIBA 10/2022 - 01/2003
12	Capecitabine (Xeloda)FDA Link 10/2020 - 12/2004
12	Lapatinib (GW572016)FDA Link 11/2018 - 12/2007
11	Biological ProductsIBA 12/2020 - 06/2006
10	taxaneIBA 10/2022 - 09/2007
10	Letrozole (Femara)FDA LinkGeneric 10/2022 - 01/2003
10	Ado-Trastuzumab EmtansineIBA 10/2022 - 09/2012
10	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2008
9	Phenobarbital (Luminal)FDA Link 01/2021 - 10/2011
9	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 06/2006
8	pertuzumabIBA 10/2022 - 10/2013
7	130-nm albumin-bound paclitaxelIBA 11/2021 - 07/2015
7	Fluorouracil (Carac)FDA LinkGeneric 10/2019 - 04/2006
6	Fulvestrant (Faslodex)FDA Link 01/2022 - 12/2014
6	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2017
6	PlatinumIBA 10/2021 - 10/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
6	Estrogens (Estrogen)FDA Link 01/2021 - 01/2008
6	Pharmaceutical PreparationsIBA 01/2020 - 02/2003
6	exemestane (Aromasin)FDA Link 07/2018 - 09/2007
5	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 07/2012
5	pembrolizumabIBA 01/2022 - 01/2020
5	atezolizumabIBA 01/2022 - 11/2018
5	cabozantinibIBA 08/2021 - 11/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 03/2010
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2002
5	Anastrozole (Arimidex)FDA LinkGeneric 02/2009 - 08/2002
5	Vinorelbine (Navelbine)FDA LinkGeneric 12/2008 - 08/2003
4	palbociclibIBA 10/2022 - 11/2020
4	B7-H1 AntigenIBA 01/2022 - 11/2018
4	neratinibIBA 01/2022 - 03/2016
4	AlpelisibIBA 01/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2022 - 03/2015
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
4	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 05/2009
3	ribociclibIBA 10/2022 - 11/2016
3	Taxoids (Taxanes)IBA 10/2022 - 12/2004
3	olaparibIBA 01/2022 - 10/2014
3	Circulating Tumor DNAIBA 01/2022 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2010
3	Cyclin-Dependent Kinase 4IBA 01/2022 - 12/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 11/2005
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021 - 10/2010
3	LigandsIBA 10/2020 - 06/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2008
3	ixabepilone (BMS 247550)FDA Link 01/2020 - 07/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2007
3	Epidermal Growth Factor (EGF)IBA 01/2019 - 12/2012
3	SteroidsIBA 01/2019 - 02/2006
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 11/2016
3	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 06/2003
3	Tyrosine Kinase InhibitorsIBA 11/2016 - 01/2004
3	Phosphotransferases (Kinase)IBA 11/2016 - 01/2004
3	Gemcitabine FDA Link 01/2016 - 12/2004
3	iniparibIBA 01/2016 - 08/2014

Therapy/Procedure

158	Therapeutics 10/2022 - 08/2002
72	Drug Therapy (Chemotherapy) 01/2022 - 06/2002
27	Adjuvant Chemotherapy 05/2022 - 04/2003
17	Radiotherapy 01/2022 - 09/2004
13	Mastectomy (Mammectomy) 01/2022 - 02/2009
12	Neoadjuvant Therapy 02/2022 - 09/2013
12	Segmental Mastectomy (Lumpectomy) 01/2022 - 11/2008
10	Aftercare (After-Treatment) 04/2021 - 12/2003
4	Immunotherapy 01/2020 - 01/2017
3	Prophylactic Mastectomy 11/2015 - 09/2013
3	Combination Drug Therapy (Combination Chemotherapy) 03/2015 - 04/2003